NCT06296316

Brief Summary

The purpose of this study is to prospectively follow patients after a sacrocolpopexy with Restorelle® mesh for apical prolapse repair as part of routine care. It will help to describe the safety profile and to confirm the clinical benefits of Restorelle mesh for at least 5 to 8 years post-surgery.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
39

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Nov 2023

Shorter than P25 for all trials

Geographic Reach
1 country

6 active sites

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 21, 2023

Completed
3 days until next milestone

First Submitted

Initial submission to the registry

November 24, 2023

Completed
3 months until next milestone

First Posted

Study publicly available on registry

March 6, 2024

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 6, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 6, 2024

Completed
Last Updated

January 28, 2026

Status Verified

January 1, 2026

Enrollment Period

12 months

First QC Date

November 24, 2023

Last Update Submit

January 26, 2026

Conditions

Keywords

Apical prolapseTransabdominal meshPelvic organ prolapseSacrocolpopexySacrocervicopexySacrohysteropexy

Outcome Measures

Primary Outcomes (1)

  • The incidence rate of a surgical reintervention related to Restorelle mesh use over at least the 5 first years of post-index procedure follow-up

    up to 5 years

Secondary Outcomes (24)

  • Incidence rate of surgical reintervention related to Restorelle mesh use in patients

    through study completion, at least 5 and up to 8 years

  • Number of patients who have only had surgical reintervention not related to Restorelle mesh use

    through study completion, at least 5 and up to 8 years

  • Percentage of patients who have only had surgical reintervention not related to Restorelle mesh use

    through study completion, at least 5 and up to 8 years

  • Number of patients who have had more than 1 surgical reintervention (unrelated to mesh use)

    5 years ; up to 8-year after index procedure

  • Percentage of patients who have had more than 1 surgical reintervention (unrelated to mesh use)

    5 years ; up to 8-year after index procedure

  • +19 more secondary outcomes

Interventions

The Coloplast Restorelle® Polypropylene Mesh is a Class III, implantable, permanent, non-absorbable, single use device indicated to restore female pelvic floor anatomy by providing anatomical support and suspension as a bridging material to support deficient fascia that resulted in descent of the female pelvic organs (pelvic organ prolapse). Restorelle mesh is a synthetic, macroporous mesh constructed of medical grade knitted, monofilament polypropylene.

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adult female patients presenting with apical pelvic organ prolapse which is clinically indicated for a surgical treatment with Restorelle mesh

You may qualify if:

  • Female patient of at least 18 years old
  • Patient presenting apical pelvic organ prolapse and being eligible to surgical treatment
  • Patient having received appropriate information and counselling before mesh implantation
  • Patient has been provided written informed consent

You may not qualify if:

  • Patient currently pregnant or breastfeeding
  • Patient being deprived of liberty by a judicial or administrative decision, or who is under a measure of legal protection

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (6)

Polyclinique de la Baie

Avranches, Choisir Une Région, 50300, France

Location

CHU Pellegrin

Bordeaux, 33076, France

Location

CH La Rochelle

La Rochelle, 17019, France

Location

Clinique Bon Secours

Le Puy-en-Velay, 43000, France

Location

Institut Mutualiste Montsouris

Paris, 75014, France

Location

CH de Saintonge

Saintes, 17108, France

Location

MeSH Terms

Conditions

Pelvic Organ Prolapse

Condition Hierarchy (Ancestors)

ProlapsePathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Study Officials

  • Philippe Ferry, Dr

    CH La Rochelle, France

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 24, 2023

First Posted

March 6, 2024

Study Start

November 21, 2023

Primary Completion

November 6, 2024

Study Completion

November 6, 2024

Last Updated

January 28, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will not share

There is not a plan to make IPD available

Locations